Tagged with UAE

UAE PharmaBoardroom highlights three pharma executives whose experience in the Middle East has served to propel them into global leadership positions.   The Middle East and North Africa region is comprised of 22 countries and has a population of nearly 400 million. The region is home to a fast-growing pharma market…

UAE The top 10 pharma companies in the UAE ranked by 2018 sales according to IQVIA data. Swiss giant Novartis leads the way with USD 196 million in sales, followed by GSK on 129 million and AstraZeneca with 126 million.   Made with Visme Infographic Maker

UAE We look at three of the most important regulatory trends in UAE healthcare and the impact they stand to have on pharma multinationals, local firms, service providers, and patients.   There are several regulatory bodies in the UAE, including the Ministry of Health and Prevention (MOHAP), the Dubai Health Authority…

UAE The UAE is putting a greater emphasis on healthcare than ever before as part of its ‘Vision 2021’ model. With the aim of being “flexible in adopting new economic models and capitalizing on global economic partnerships,” the Emirates are seeing greater numbers of investments and partnerships in healthcare, many of…

MENA The Middle East and North Africa (MENA) region’s pharmaceutical market is projected to reach a value of around USD 60 billion by 2025 according to reporting from TradeArabia. The most impressive growth is coming from the UAE, but North African giants Egypt and Algeria are also significant contributors.   Factors…

UAE How quickly can a country truly transform its healthcare system, while making it sustainable for the future? The mindset of Emiratis is that anything that is feasible and beneficial for the country should and will be done, regardless of the cost. This is why health authorities have been moving at…

UAE “Over the past twenty years, we have seen a drastic change in the socio-economic climate of the Gulf region and neighboring countries. There has been considerable growth in terms of wealth and a sharp increase in health expenditures, which was mandated by the Ministry of Health”, explains Ayman Sahli, CEO…

UAE Amin Al Amiri, Assistant undersecretary for Medical Practice and Licensee of Ministry of Health, UAE, discusses why the UAE, despite turmoil in the rest of the Middle East region, continues to be a destination for the pharmaceutical industry, how MOH plans on supporting standardization across the region, and how recruiting…

UAE Mohammed Zafrullah, VP & General Manager of GlaxoSmithKline (GSK) Pharmaceuticals, argues that the UAE, despite recent turmoil in the rest of the Middle East, is the perfect emerging country to do build a business in due to the many opportunities for innovation and growth.   To have a successful business,…

UAE Dr Omar Ghosheh, Chief Executive Officer of Dimensions Healthcare, examines what it takes to build a company in Dubai, why it is the perfect city for healthcare companies and why patience always pays off in the end.   What are the main services that Dimensions is known for? It’s a…

Lilly Huzur Devletsah, General Manager of the Gulf and Near East regions of Lilly, talks about the political instability in other parts of the region, the lack of an adequate talent pool in the industry, and what this all means for the future growth of Lilly.   With the inauguration of…

Abbvie Bassel Amer, Regional General Manager of Abbvie, discusses the company’s split in 2012, why it has been a good thing for both sides and everyone involved, including shareholders, and where he sees the Middle East market in the next five to ten years. On January 2012, Abbott split into two…